Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1210/CLINEM/DGAB812 | ||||
| Año | 2022 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Context First-degree relatives of women with polycystic ovary syndrome (PCOS) present hormonal and metabolic alterations compared to girls unrelated to PCOS. It is unknown whether glucose intolerance in the PCOS proband confers a more severe metabolic predisposition on their first-degree relatives. Objective To determine whether glucose tolerance status in women with PCOS is associated with worsened glucose metabolism and sex hormone levels in their peripubertal daughters or sisters. Design Cross-sectional study. Setting Seven academic centers in North America, South America, and Europe. Patients Sixty-four pairs of women with PCOS and their daughters or younger sisters aged between 8 and 14 years were recruited. Twenty-five mothers or older sisters with PCOS were glucose intolerant (GI) and 39 were normal glucose tolerant (NGT). Main Outcome Measures Beta-cell function estimated by the insulin secretion-sensitivity index-2 (ISSI-2) during an oral glucose tolerance test and by the disposition index during a frequently sampled IV glucose tolerance test. Free testosterone and 17-hydroxyprogesterone (17-OHP) levels. Results Being related to a GI PCOS proband was associated with a lower ISSI-2 (P-value = 0.032) after adjusting for ethnicity, body mass index z-score, and pubertal stage. They also had higher free testosterone (P-value = 0.011) and 17-OHP levels compared to girls with an NGT proband, the latter becoming significant after adjusting for confounders (P-value = 0.040). Conclusions Compared to first-degree female relatives of women with PCOS and NGT, first-degree relatives of women with PCOS and GI display lower beta-cell function and hyperandrogenemia, putting them at higher risk of GI and PCOS development.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Harnois-Leblanc, Soren | - |
CHU Sherbrooke - Canadá
UNIV MONTREAL - Canadá Centre Hospitalier Universitaire de Sherbrooke - Canadá University of Montreal - Canadá Université de Sherbrooke - Canadá |
| 2 | HERNANDEZ-CARDENAS, MARIA ISABEL | Mujer |
UNIV MONTREAL - Canadá
Universidad de Chile - Chile University of Montreal - Canadá |
| 3 | CODNER-DUJOVNE, ETHEL | Mujer |
Universidad de Chile - Chile
|
| 4 | CASSORLA-GOLUBOFF, FERNANDO JAVIER | Hombre |
Universidad de Chile - Chile
|
| 5 | Oberfield, Sharon E. | Mujer |
Columbia Univ - Estados Unidos
Columbia University Irving Medical Center - Estados Unidos |
| 6 | Leibel, Natasha | Mujer |
Columbia Univ - Estados Unidos
Columbia University Irving Medical Center - Estados Unidos |
| 7 | Mathew, R. | - |
Vanderbilt Univ - Estados Unidos
Vanderbilt University School of Medicine - Estados Unidos |
| 8 | Ten, Svetlana | Mujer |
Richmond Univ - Estados Unidos
Richmond University Medical Center - Estados Unidos |
| 9 | Magoffin, Denis A. | Hombre |
Cedars Sinai Med Ctr - Estados Unidos
Cedars-Sinai Medical Center - Estados Unidos |
| 10 | Lane, Christianne J. | Mujer |
Univ Southern Calif - Estados Unidos
Keck School of Medicine of USC - Estados Unidos |
| 11 | Goran, Michael | Hombre |
Univ Southern Calif - Estados Unidos
Keck School of Medicine of USC - Estados Unidos |
| 12 | Azziz, R. | Hombre |
Univ Alabama Birmingham - Estados Unidos
SUNY Albany - Estados Unidos University of Alabama at Birmingham School of Medicine - Estados Unidos School of Public Health - Estados Unidos Heersink School of Medicine - Estados Unidos |
| 13 | Baillargeon, Jean-Patrice | Hombre |
CHU Sherbrooke - Canadá
Univ Sherbrooke - Canadá Centre Hospitalier Universitaire de Sherbrooke - Canadá Université de Sherbrooke - Canadá |
| 14 | Geller, David H. | Hombre |
Univ Southern Calif - Estados Unidos
Childrens Hosp Los Angeles - Estados Unidos Keck School of Medicine of USC - Estados Unidos Children's Hospital Los Angeles - Estados Unidos |
| Fuente |
|---|
| FONDECYT |
| National Institute of Child Health and Human Development |
| National Institute of Diabetes and Digestive and Kidney Diseases |
| National Center for Research Resources |
| NIH grant National Institute of Child Health and Human Development (NICHD) |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (National Center for Research Resources [NCRR]) |
| Fonds de Recherche du Quebec-Sante PhD Award for Health Professionals |
| Helping Hand of Los Angeles, Inc. |
| NIH grant National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Department of Medicine award at Universite de Sherbrooke |
| individual Clinical Research Feasibility Fund award |
| Fonds de Recherche du QuebecSante Senior Investigator Award |
| Faculty of Medicine and Health Sciences at Universite de Sherbrooke Graduate award |
| Agradecimiento |
|---|
| This study was supported by NIH grants National Institute of Child Health and Human Development (NICHD) K23 1HD40325 (to D.H.G.), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) RO1 59211 (to M.I.G.), M01-RR00425 (to R.A.), MO1-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources [NCRR]), and Fondecyt Grant 1170895 (to E.C.). S.H-L. was supported by Faculty of Medicine and Health Sciences at Universite de Sherbrooke Graduate award and is currently supported by Fonds de Recherche du Quebec-Sante PhD Award for Health Professionals. R.A. is supported by an endowment from the Helping Hand of Los Angeles, Inc. J-P.B. is supported by Fonds de Recherche du QuebecSante Senior Investigator Award and a Department of Medicine award at Universite de Sherbrooke. D.H.G. is supported by an individual Clinical Research Feasibility Fund award. |